Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J M Gijtenbeek

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Neurology|August 29, 2001
Primary central nervous system T-cell lymphomaJ M Gijtenbeek, M K Rosenblum, L M DeAngelis
Journal of Neurology|July 10, 1999
Cyclosporine neurotoxicity: a reviewJ M Gijtenbeek, M J van den Bent, C J Vecht
Clinical Neurology and Neurosurgery|December 1, 1993
Surgery for intracranial meningiomas in elderly patientsJ M Gijtenbeek, W C Hop, R Braakman, et al.
Clinical Neurology and Neurosurgery|November 1, 1994
Different types of plasminogen activator activity in human brain tumours: relation with peritumoral oedema?J M Gijtenbeek, J J Emeis, J J van der Sande, et al.
Neurology|June 27, 2001
Mononeuropathy multiplex as the initial manifestation of neurofibromatosis type 2J M Gijtenbeek, A A Gabreëls-Festen, M Lammens, et al.
Journal of Neuro-Oncology|August 25, 2001
Characteristic chromosomal aberrations in sporadic cerebellar hemangioblastomas revealed by comparative genomic hybridizationS H Sprenger, J M Gijtenbeek, P Wesseling, et al.
Neurology|July 13, 2006
CSF levels of growth factors and plasminogen activators in leptomeningeal metastasesB van de Langerijt, J M Gijtenbeek, H P M de Reus, et al.
Trials|June 17, 2025
[<sup>18</sup>F]FET PET-Guided management of pseudoprogression in glioblastoma (FET POPPING): the study protocol for a diagnostic randomized clinical trialV J Ruijters, T J Snijders, J A J van der Pol, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Neurology|August 29, 2001
Primary central nervous system T-cell lymphomaJ M Gijtenbeek, M K Rosenblum, L M DeAngelis
Journal of Neurology|July 10, 1999
Cyclosporine neurotoxicity: a reviewJ M Gijtenbeek, M J van den Bent, C J Vecht
Clinical Neurology and Neurosurgery|December 1, 1993
Surgery for intracranial meningiomas in elderly patientsJ M Gijtenbeek, W C Hop, R Braakman, et al.
Clinical Neurology and Neurosurgery|November 1, 1994
Different types of plasminogen activator activity in human brain tumours: relation with peritumoral oedema?J M Gijtenbeek, J J Emeis, J J van der Sande, et al.
Neurology|June 27, 2001
Mononeuropathy multiplex as the initial manifestation of neurofibromatosis type 2J M Gijtenbeek, A A Gabreëls-Festen, M Lammens, et al.
Journal of Neuro-Oncology|August 25, 2001
Characteristic chromosomal aberrations in sporadic cerebellar hemangioblastomas revealed by comparative genomic hybridizationS H Sprenger, J M Gijtenbeek, P Wesseling, et al.
Neurology|July 13, 2006
CSF levels of growth factors and plasminogen activators in leptomeningeal metastasesB van de Langerijt, J M Gijtenbeek, H P M de Reus, et al.
Trials|June 17, 2025
[<sup>18</sup>F]FET PET-Guided management of pseudoprogression in glioblastoma (FET POPPING): the study protocol for a diagnostic randomized clinical trialV J Ruijters, T J Snijders, J A J van der Pol, et al.
Pageof 1